Phase I / II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
James R. Berenson, Ori Yellin, Alberto Bessudo, Ralph V. Boccia et autres
us (code pays fourni par la source)